Related Experiment Videos
[National Register of congenital hypothyroidism]
M Sorcini Carta1, C Fazzini, A Olivieri
1Laboratorio di Metabolismo e Biochimica Patologica, Istituto Superiore di Sanità, Roma.
Insights
The National Register of children with Congenital Hypothyroidism (CH) in Italy has improved screening and treatment. Five years of data show enhanced epidemiological information and better therapy initiation and dosage.
Area of Science:
- Pediatrics
- Endocrinology
- Public Health
Context:
- Established in 1987, the National Register of children with Congenital Hypothyroidism (NRCH) is a pilot project involving all Italian centers for CH care.
- The NRCH collects data on screening, treatment, and follow-up for children diagnosed with Congenital Hypothyroidism.
Purpose:
- To evaluate five years of activity of the NRCH.
- To gather epidemiological data on Congenital Hypothyroidism in Italy.
- To identify areas for improvement in CH screening and management.
Summary:
- Analysis of NRCH data provided epidemiological insights into Congenital Hypothyroidism prevalence in Italy.
- The evaluation highlighted specific aspects of screening organization requiring enhancement.
- Regular discussion of Register data has led to improvements in the initiation of treatment and therapeutic dosages.
Impact:
- Improved understanding of Congenital Hypothyroidism epidemiology in the Italian pediatric population.
- Enhanced screening protocols and organizational strategies for Congenital Hypothyroidism.
- Optimized treatment initiation and dosage regimens for affected children, leading to better outcomes.
Abstract:
The results of five years activity of the National Register of children with Congenital Hypothyroidism (NRCH) have been evaluated. NRCH was established in Italy in 1987, as a pilot project of Health Ministry. All Italian Centers in charge of the screening, treatment and follow-up of CH are involved in the program. The results have provided further epidemiological informations about CH in Italy and have evidenced some aspects in the screening organization which had to be improved. Discussion of Register data in annual meetings has recently allowed to obtain an improvement especially for the beginning of treatment and the used dose of therapy.